Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Blake Gardner

Interventional Cardiology St George, UT Medical Doctor

NPI 1134301997 CMS profile 5670

1380 E Medical Center Dr Ste 1500, St George, UT 84790

Open in the dashboard

General payments

$266,690

732 records reported · program years 2019–2025

Research payments

$14,563

Paid to them · 23 records reported · program years 2019–2025

Ownership & investment interest

$0

None reported

Research they led as principal investigator

$190,582 paid to institutions, not to them · program years 2020–2025

Through program year 2025, Blake Gardner of St George, UT is reported in the CMS Open Payments database as having received $266,690 across 732 general payments and $14,563 in research payments paid to them. Separately, studies naming them as principal investigator received $190,582 in research payments, paid to institutions rather than to them.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them. The principal-investigator line is research money paid to institutions for studies they led — not to them — and is not added to anything either.

General payments for this record sit in the 97th percentile of Interventional Cardiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

11 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $922 22
2024 General $11,721 62
2023 General $16,906 101
2023 Research $1,031 4
2022 General $60,732 166
2022 Research $3,469 12
2021 General $102,205 198
2021 Research $5,063 6
2020 General $61,459 121
2020 Research $5,000 1
2019 General $12,746 62

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Blake Gardner
  • Interventional Cardiology median
  • Middle half of Interventional Cardiology
  • National median

In program year 2025, general payments to Blake Gardner were reported at $922. Among 6,173 Interventional Cardiology profiles paid that year, the median was $1,092 and the middle half received between $366 and $3,019.

Show as a table
Year Blake Gardner Interventional Cardiology median Middle half National median
2019 $12,746 $1,097 $329–$3,048 $163
2020 $61,459 $473 $161–$1,480 $114
2021 $102,205 $677 $233–$1,827 $132
2022 $60,732 $978 $333–$2,724 $149
2023 $16,906 $1,136 $382–$2,986 $160
2024 $11,721 $1,181 $395–$3,326 $164
2025 $922 $1,092 $366–$3,019 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Medtronic, Inc. $180,024 439 payments
  2. Medtronic Vascular, Inc. $69,126 153 payments
  3. Boston Scientific Corporation $7,921 74 payments
  4. Edwards Lifesciences Corporation $4,860 29 payments
  5. Abbott Laboratories $2,366 33 payments
  6. Integer Holdings Corporation $2,292 1 payment
  7. Shockwave Medical, Inc $74 1 payment
  8. Pfizer Inc. $27 2 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $151,000 78 payments
  2. Travel and Lodging $68,441 180 payments
  3. Consulting Fee $30,305 7 payments
  4. Food and Beverage $16,944 467 payments
Products named General payments · program years 2019–2025
  1. CoreValve Evolut Transcatheter Valve Systems $89,583 162 payments
  2. CoreValve Evolut Transcatheter Valve Systems $68,819 144 payments
  3. COREVALVE EVOLUT R $63,115 210 payments
  4. General Therapies $2,304 11 payments
  5. Abbott (Circulo) TAVR project $2,292 1 payment
  6. WATCHMAN $2,279 9 payments
  7. PASCAL $1,758 10 payments
  8. EVOQUE $1,547 6 payments
  9. AMPLATZER Occluders $1,449 8 payments
  10. General - Therapies $1,430 2 payments
  11. Other $4,117 93 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic, Inc. $9,563 22 payments
  2. Medtronic Vascular, Inc. $5,000 1 payment

Billing to Medicare

Part B · data year 2024 · 19 billing codes

Paid by Medicare

$70,634

Medicare's payments for the services billed

Medicare patients

117

Average age 81

Services billed

236

43 women, 74 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Heart failure 75%
Ischemic heart disease 75%
Arthritis 59%
Atrial fibrillation 52%
Chronic kidney disease 44%
Diabetes 32%
Depression 27%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ELIQUIS
  • PFIZER INC. $27
$27 — —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

755 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Interventional Cardiology in Utah

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record